Evidence map›Paper›PMID 19931444›Full record

ArticleThe International journal on drug policy2010

Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

R Douglas Bruce

Abstract read
In one paragraph

Article in The International journal on drug policy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A qualitative study of emergency department patients who survived an opioid overdose: Perspectives on treatment and unmet needs.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. The Opioid Epidemic in Africa And Its Impact.Current addiction reports · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

R Douglas BruceYale University, School of Medicine, AIDS Programme, 135 College Street, Suite 323, New Haven, CT 06510, United States. Robert.bruce@yale.edu
Yale University · US

Funding

Substance Abuse, HIV and HCV Treatments to Improve Health Outcomes in Drug UsersK23DA022143 · NIDA · YALE UNIVERSITY · PI BRUCE, ROBERT D · 2006 to 2010
$881k
NIDA NIH HHS K23 DA022143
6 · The paper itself

Abstract

The link between injection drug use and HIV has been extensively described. Despite worldwide prevention efforts, injection drug use continues to be a risk factor for HIV transmission and both HIV and injection drug use continues to spread across the globe. Although methadone has demonstrated multiple health benefits including the reduction in injection drug use and HIV acquisition, the utilisation of methadone in many areas of the world remains one of secondary, rather than primary, HIV prevention. As a result, many who finally begin methadone enter treatment having accumulated medical and mental health problems as a result of delayed treatment. Rapid access to treatment and a more aggressive policy that realizes that methadone can help reduce opioid drug use is necessary if methadone is effectively going to act as primary HIV prevention. To delay access to methadone only increases the probability that the individual will acquire an infectious disease that is more costly to the individual in terms of morbidity and mortality and more costly to society as a whole.

Indexed as

Harm ReductionDeveloping CountriesDisease OutbreaksHealth Services AccessibilityHIV InfectionsHumansIncidenceMethadonePreventive Health ServicesRisk FactorsSubstance Abuse, IntravenousMethadone

Identifiers

PMID19931444
PMCPMC2839048
OpenAlexW2110916536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.